The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor
Open accessAbstract
The non-peptide CXCR4 receptor antagonist AMD3100, which is a potent blocker of human immunodeficiency virus cell entry, is a symmetrical bicyclam composed of two identical 1,4,8,11-tetraazacyclotetradecane (cyclam) moieties connected by a relatively rigid phenylenebismethylene linker. Based on the known strong propensity of the cyclam moiety to bind carboxylic acid groups, receptor mutagenesis identified Asp(171) and Asp(262), located in transmembrane domain (TM) IV and TM-VI, respectively, at each end of the main ligand-binding crevice of the CXCR4 receptor, as being essential for the ability of AMD3100 to block the binding of the chemokine ligand stromal cell-derived factor (SDF)-1alpha as well as the binding of the receptor antibody 12G5. The free cyclam moiety had no effect on 12G5 binding, but blocked SDF-1alpha binding with an affinity of 3 microm through interaction with Asp(171). The effect on SDF-1alpha binding of a series of bicyclam analogs with variable chemical linkers was found to rely either only on Asp(171), i.e. the bicyclams acted as the isolated cyclam, or on both Asp(171) and Asp(262), i.e. they acted as AMD3100, depending on the length and the chemical nature of the linker between the two cyclam moieties. A positive correlation was found between the dependence of these compounds on Asp(262) for binding and their potency as anti-human immunodeficiency virus agents. It is concluded that AMD3100 acts on the CXCR4 receptor through binding to Asp(171) in TM-IV and Asp(262) in TM-VI with each of its cyclam moieties, and it is suggested that part of its function is associated with a conformational constraint imposed upon the receptor by the connecting phenylenebismethylene linker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,399
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Thermodynamic and kinetic data for macrocycle interactions with cations and anions
Izatt, R. M., Pawlak, K., Bradshaw, J. S., & Bruening, R. L. (1991) · Chemical Reviews · doi:10.1021/cr00008a003 · Cited by 1,945
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., DeClercq, E., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-072 · Cited by 760
Crump, M. P., Gong, J., Loetscher, P., Rajarathnam, K., Amara, A., Arenzana‐Seisdedos, F., Virelizier, J., Baggiolini, M., Sykes, B. D., & Clark‐Lewis, I. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6996 · Cited by 731
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Hendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridger, G., & Henson, G. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1667-1673.2000 · Cited by 504
Self-citationSignoret, N., Oldridge, J., Pelchen-Matthews, A., Klasse, P. J., Tran, T., Brass, L. F., Rosenkilde, M. M., Schwartz, T. W., Holmes, W., Dallas, W., et al. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.3.651 · Cited by 375
Self-citationDe Clercq, E., Yamamoto, N., Pauwels, R., Balzarini, J., Witvrouw, M., De Vreese, K., Debyser, Z., Rosenwirth, B., Peichl, P., & Datema, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.668 · Cited by 296
Locating ligand-binding sites in 7tm receptors by protein engineering
Schwartz, T. W. (1994) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(94)90054-x · Cited by 274
Self-citationDe Clercq, E., Yamamoto, N., Pauwels, R., Baba, M., Schols, D., Nakashima, H., Balzarini, J., Debyser, Z., Murrer, B. A., & Schwartz, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5286 · Cited by 242
Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4
Schols, D., Esté, J. A., Henson, G., & De Clercq, E. (1997) · Antiviral Research · doi:10.1016/s0166-3542(97)00025-9 · Cited by 220
Bridger, G. J., Skerlj, R. T., Thornton, D., Padmanabhan, S., Martellucci, S. A., Henson, G. W., Abrams, M. J., Yamamoto, N., & Vreese, K. D. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00002a019 · Cited by 209
Self-citationBrelot, A., Heveker, N., Pleskoff, O., Sol, N., & Alizon, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4744-4751.1997 · Cited by 172
Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor
Elling, C. E., Nielsen, S. M., & Schwartz, T. W. (1995) · Nature · doi:10.1038/374074a0 · Cited by 162
Self-citationJohansen, T. E., Schøller, M. S., Tolstoy, S., & Schwartz, T. W. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80947-h · Cited by 159
Self-citationLabrosse, B., Brelot, A., Heveker, N., Sol‐Foulon, N., Schols, D., Clercq, E. D., & Alizon, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6381-6388.1998 · Cited by 142
Differential regulation of CXCR4 and CCR5 endocytosis
Signoret, N. Y. M., ROSENKILDE, M. M., Klasse, P. J., Schwartz, T. W., Malim, M. H., Hoxie, J. A., & Marsh, M. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.18.2819 · Cited by 142
Self-citationThe molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
de Vreese, K., Kofler-Mongold, V., Leutgeb, C., Weber, V., Vermeire, K., Schacht, S., Anné, J., Clercq, E. D., DATEMA, R., & Werner, G. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.689-696.1996 · Cited by 130
Inhibition of HIV Infection by Bicyclams, Highly Potent and Specific CXCR4 Antagonists
Clercq, E. D. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26490-7 · Cited by 114
Conversion of agonist site to metal-ion chelator site in the β 2 -adrenergic receptor
Elling, C., Thirstrup, K., Holst, B., & Schwartz, T. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12322 · Cited by 108
Self-citationEsté, J. A., Cabrera, C., Clercq, E. D., Struyf, S., Damme, J. V., Bridger, G. J., Skerlj, R. T., Abrams, M. J., Henson, G. W., Gutiérrez, A., et al. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23157-6 · Cited by 101
Self-citationGether, U., Johansen, T. E., & Schwartz, T. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53041-6 · Cited by 98
Self-citationBicyclam derivatives as HIV inhibitors
Bridger, G. J., & Skerlj, R. T. (1999) · Advances in antiviral drug design · doi:10.1016/s1075-8593(99)80007-0 · Cited by 15
Self-citation
Cited by
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Teicher, B. A., & Fricker, S. P. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2329 · Cited by 1,449
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Kioi, M., Vogel, H., Schultz, G., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 773
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
Liles, W. C., Broxmeyer, H. E., Rodger, E., Wood, B., Hübel, K., Cooper, S., Hangoc, G., Bridger, G. J., Henson, G. W., Calandra, G., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0663 · Cited by 718
Self-citationA small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
Metadata
- Authors
- Gerlach, L. O., Skerlj, R. T., Bridger, G. J., & Schwartz, T. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 276
- Issue
- 17
- Pages
- 14153-14160
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1501974099
- Cited by
- 260
- References
- 24
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.